Aehr Test Systems, Inc. (NASDAQ:AEHR) shareholders are no doubt pleased to see that the share price has bounced 30% in the last month, although it is still struggling to make up recently lost ground. Still, the 30-day jump doesn't change the fact that longer term shareholders have seen their stock decimated by the 50% share price drop in the last twelve months.
Even after such a large jump in price, Aehr Test Systems' price-to-earnings (or "P/E") ratio of 15.9x might still make it look like a buy right now compared to the market in the United States, where around half of the companies have P/E ratios above 19x and even P/E's above 35x are quite common. However, the P/E might be low for a reason and it requires further investigation to determine if it's justified.
Aehr Test Systems certainly has been doing a great job lately as it's been growing earnings at a really rapid pace. One possibility is that the P/E is low because investors think this strong earnings growth might actually underperform the broader market in the near future. If you like the company, you'd be hoping this isn't the case so that you could potentially pick up some stock while it's out of favour.
We don't have analyst forecasts, but you can see how recent trends are setting up the company for the future by checking out our free report on Aehr Test Systems' earnings, revenue and cash flow.
Does Growth Match The Low P/E?
Aehr Test Systems' P/E ratio would be typical for a company that's only expected to deliver limited growth, and importantly, perform worse than the market.
Retrospectively, the last year delivered an exceptional 52% gain to the company's bottom line. Although, its longer-term performance hasn't been as strong with three-year EPS growth being relatively non-existent overall. Accordingly, shareholders probably wouldn't have been overly satisfied with the unstable medium-term growth rates.
Weighing that recent medium-term earnings trajectory against the broader market's one-year forecast for expansion of 15% shows it's noticeably less attractive on an annualised basis.
In light of this, it's understandable that Aehr Test Systems' P/E sits below the majority of other companies. Apparently many shareholders weren't comfortable holding on to something they believe will continue to trail the bourse.
The Key Takeaway
Aehr Test Systems' stock might have been given a solid boost, but its P/E certainly hasn't reached any great heights. We'd say the price-to-earnings ratio's power isn't primarily as a valuation instrument but rather to gauge current investor sentiment and future expectations.
We've established that Aehr Test Systems maintains its low P/E on the weakness of its recent three-year growth being lower than the wider market forecast, as expected. At this stage investors feel the potential for an improvement in earnings isn't great enough to justify a higher P/E ratio. If recent medium-term earnings trends continue, it's hard to see the share price rising strongly in the near future under these circumstances.
You need to take note of risks, for example - Aehr Test Systems has 3 warning signs (and 1 which is a bit concerning) we think you should know about.
Of course, you might find a fantastic investment by looking at a few good candidates. So take a peek at this free list of companies with a strong growth track record, trading on a low P/E.
Have feedback on this article? Concerned about the content?Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Aehr Test Systems公司(纳斯达克:AEHR)的股东无疑很高兴看到股价在上个月反弹了30%,尽管股价仍在努力弥补最近的跌幅。然而,30天的涨幅并未改变长期股东在过去十二个月中看到股价暴跌50%的事实。
即使股价大幅上涨,相较于美国市场,Aehr Test Systems的市盈率(即“P/E”)为15.9倍,这仍然可能看起来像是一个不错的买入时机,因为美国约一半的公司的P/E比率超过19倍,甚至P/E在35倍以上非常普遍。然而,P/E可能之所以偏低是有原因的,需要进一步调查才能确定是否合理。
最近Aehr Test Systems做得确实很不错,因为其盈利一直以非常快速的速度增长。一个可能的原因是,P/E之所以偏低是因为投资者认为这种强劲的盈利增长实际上可能在不久的将来表现不如更广泛的市场。如果您喜欢这家公司,您希望不是这种情况,这样您就有可能在它不受青睐时买入一些股票。
我们没有分析师预测,但您可以通过查看我们关于Aehr Test Systems盈利、营业收入和现金流的免费报告,了解最近的趋势如何为该公司未来做准备。
增长是否符合低市盈率?
Aehr Test Systems的市盈率对于一个预计只能实现有限增长,并且重要的是表现不如市场的公司来说是典型的。